CME: The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?

Be part of the knowledge.

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?

CME/CE Broadcast Replay

The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
This previously-aired broadcast provides a brief overview of the newest HPV screening recommendations and answers the audience’s pressing questions.

Available credits: 0.50

Time to complete: 30 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    The Cervical Cancer Screening practice environment continues to change for both physicians and patients. Physicians are constantly tasked with evaluating analyses of new data on how best to approach cervical cancer screening for a particular patient demographic; and patients remain confused and unsure if the “new” approaches are better, or even less safe, than the “Pap” that has served as the bedrock for so many years.

    This activity previously aired as a ReachMD Live Broadcast, where Dr. Thomas Wright, Jr., addressed these wide-ranging issues in a real-time, question and answer forum.

  • Disclaimer

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Jennifer Caudle, DO
    Family Medicine Physician and Assistant Professor
    Department of Family Medicine
    Rowan University-School of Osteopathic Medicine
    Stratford, New Jersey

    Dr. Caudle has no financial relationships to disclose. 

    Thomas C. Wright, Jr., MD
    Professor Emeritus of Pathology and Cell Biology
    Columbia University
    New York, NY

    Dr. Wright receives consulting fees from Abbott, BD, and Roche; and contracted research from BD, Inovio, and Roche. 


    • Sean T. Barrett has nothing to disclose.
    • Carole Drexel, PhD has nothing to disclose.
    • Barry A. Fiedel, PhD has nothing to disclose. 
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    1. Summarize the emergent USPSTF draft recommendations and their potential impact toward a more unified strategy for cervical cancer screening and triage in the US.
    2. Analyze the growing real-world experience with primary HPV screening as the preferred approach when assessing a woman's risk for developing cervical cancer to facilitate its adoption in US practices as recommended by the USPSTF.
    3. Formulate strategies to manage discussions with patients when addressing the duration period between cervical cancer screenings.
  • Target Audience

    This activity is designed to meet the educational needs of the obstetrician and gynecologist, family physician, internal medicine physician, physician assistant, nurse practitioner, and certified nurse midwife.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

  • Commercial Support

    This activity is supported by an independent educational grant from Roche Diagnostics.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.